Dr William Leonard Phillips, MD | |
2223 Mission Way, Billings, MT 59102-0160 | |
(406) 237-8989 | |
(406) 237-8990 |
Full Name | Dr William Leonard Phillips |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 31 Years |
Location | 2223 Mission Way, Billings, Montana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831190685 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 12355 (Montana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St John's United Home Health | Billings, MT | Home health agency |
St Vincent Healthcare | Billings, MT | Hospital |
St John's Lutheran Home | Billings, MT | Nursing home |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Scl Health Medical Group - Billings Llc | 9638491574 | 219 |
News Archive
Research from the University of Kent has demonstrated a decline in 'son preference' by women of childbearing age in Bangladesh. However, the study also shows that fertility decisions are still influenced according to son preference.
In a recent and timely paper, currently available on the bioRxiv preprint server, researchers from Israel and France demonstrated how in vitro evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD) follows contagious mutation spread – but can also generate an efficient infection inhibitor.
Alverix, Inc., a world leader in the design and manufacture of next-generation platforms for diagnostic Point-of-Care (POC) testing, today announced that BD Diagnostics, a segment of Becton Dickinson and Company, a leading global medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD VeritorTM System for Rapid Detection of respiratory syncytial virus (RSV).
In a paper published on the bioRxiv* preprint server, researchers report new monoclonal antibodies that target the S2 subunit and that have broad neutralization activity against several betacoronaviruses.
› Verified 3 days ago
Entity Name | Scl Health Montana |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083655997 PECOS PAC ID: 3476457714 Enrollment ID: O20031229000380 |
News Archive
Research from the University of Kent has demonstrated a decline in 'son preference' by women of childbearing age in Bangladesh. However, the study also shows that fertility decisions are still influenced according to son preference.
In a recent and timely paper, currently available on the bioRxiv preprint server, researchers from Israel and France demonstrated how in vitro evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD) follows contagious mutation spread – but can also generate an efficient infection inhibitor.
Alverix, Inc., a world leader in the design and manufacture of next-generation platforms for diagnostic Point-of-Care (POC) testing, today announced that BD Diagnostics, a segment of Becton Dickinson and Company, a leading global medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD VeritorTM System for Rapid Detection of respiratory syncytial virus (RSV).
In a paper published on the bioRxiv* preprint server, researchers report new monoclonal antibodies that target the S2 subunit and that have broad neutralization activity against several betacoronaviruses.
› Verified 3 days ago
Entity Name | Scl Health Medical Group - Billings Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508289703 PECOS PAC ID: 9638491574 Enrollment ID: O20141204001495 |
News Archive
Research from the University of Kent has demonstrated a decline in 'son preference' by women of childbearing age in Bangladesh. However, the study also shows that fertility decisions are still influenced according to son preference.
In a recent and timely paper, currently available on the bioRxiv preprint server, researchers from Israel and France demonstrated how in vitro evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD) follows contagious mutation spread – but can also generate an efficient infection inhibitor.
Alverix, Inc., a world leader in the design and manufacture of next-generation platforms for diagnostic Point-of-Care (POC) testing, today announced that BD Diagnostics, a segment of Becton Dickinson and Company, a leading global medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD VeritorTM System for Rapid Detection of respiratory syncytial virus (RSV).
In a paper published on the bioRxiv* preprint server, researchers report new monoclonal antibodies that target the S2 subunit and that have broad neutralization activity against several betacoronaviruses.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr William Leonard Phillips, MD 2223 Mission Way, Billings, MT 59102-0160 Ph: (406) 237-8989 | Dr William Leonard Phillips, MD 2223 Mission Way, Billings, MT 59102-0160 Ph: (406) 237-8989 |
News Archive
Research from the University of Kent has demonstrated a decline in 'son preference' by women of childbearing age in Bangladesh. However, the study also shows that fertility decisions are still influenced according to son preference.
In a recent and timely paper, currently available on the bioRxiv preprint server, researchers from Israel and France demonstrated how in vitro evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD) follows contagious mutation spread – but can also generate an efficient infection inhibitor.
Alverix, Inc., a world leader in the design and manufacture of next-generation platforms for diagnostic Point-of-Care (POC) testing, today announced that BD Diagnostics, a segment of Becton Dickinson and Company, a leading global medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD VeritorTM System for Rapid Detection of respiratory syncytial virus (RSV).
In a paper published on the bioRxiv* preprint server, researchers report new monoclonal antibodies that target the S2 subunit and that have broad neutralization activity against several betacoronaviruses.
› Verified 3 days ago
Michael D. Monday, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1775 Spring Creek Dr, Billings, MT 59102 Phone: 406-373-3500 Fax: 406-373-3520 | |
Aaron James Audet, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Angel M. Eads, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 S 27th St, Billings, MT 59101 Phone: 406-247-3220 Fax: 406-651-6406 | |
John Konow, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 123 S 27th St, Billings, MT 59101 Phone: 406-247-3350 Fax: 406-247-3389 | |
Cynthia Kay Brewer, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Amy Solomon, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 S 27th St, Billings, MT 59101 Phone: 406-247-3350 Fax: 406-247-3389 | |
Lawrence A. Hemmer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2675 Central Ave, Billings, MT 59102 Phone: 406-238-2500 |